CONVERTIBLE NOTE PURCHASE
AGREEMENT
This CONVERTIBLE
NOTE PURCHASE AGREEMENT (this “ Agreement ”),
dated May 6, 2009, is entered into by and between Premier
Exhibitions, Inc., a Florida corporation (the “
Company ”), and Sellers Capital Master Fund, Ltd., an
exempted company organized under the laws of the Cayman Islands
(the “ Investor ”).
WHEREAS, the
Investor desires to purchase from the Company, and the Company
desires to sell to the Investor, upon the terms and subject to the
conditions of this Agreement, a Convertible Note (the “
Convertible Note ”), in the principal amount set forth
on Schedule A hereto;
WHEREAS, the
Convertible Note will be issued in the form attached hereto as
Exhibit A ; and
WHEREAS, subject
to the terms contained herein and the Convertible Note, the
Convertible Note shall be convertible into shares of common stock,
par value $0.0001, of the Company (“ Common Stock
”), in accordance with the terms hereof and the Convertible
Note.
NOW, THEREFORE, in
consideration of the foregoing and of the respective covenants and
undertakings hereunder and for other good and valuable
consideration, the receipt and adequacy of which are hereby
acknowledged, intending to be legally bound, the parties hereto do
hereby agree as follows:
Section 1.01.
Definitions . As used in this Agreement, the following terms
have the meanings set forth below:
“
Affiliate ” shall mean with respect to a Person, any
Person which directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common
control with such Person or entity.
“
Agreement ” shall have the meaning set forth in the
preamble.
“ Annual
Meeting ” shall have the meaning set forth in
Section 5.01.
“
Closing ” shall have the meaning set forth in
Section 2.02(a).
“ Closing
Date ” shall have the meaning set forth in
Section 2.02(a).
“
Commission Filings ” shall have the meaning set forth
in Section 3.06.
1
“ Common
Stock ” shall have the meaning set forth in the
recitals.
“
Company ” shall have the meaning set forth in the
preamble.
“
Consents ” shall mean all governmental and third party
consents, approvals, authorizations, qualifications and waivers
necessary to be received by a Person for the consummation of the
transactions contemplated hereby.
“
Contract ” shall mean any contract, agreement,
mortgage, deed of trust, bond, loan, indenture, lease, license,
note, option, warrant, right, instrument, commitment or other
similar document, arrangement or agreement, whether written or
oral.
“
Conversion Shares ” shall mean the shares of Common
Stock issuable upon conversion of the Convertible Note in
accordance with its terms.
“
Convertible Note ” shall have the meaning set forth in
the recitals.
“
Exchange Act ” shall mean the Securities Exchange Act
of 1934, as amended, and the rules and regulations of the SEC
promulgated thereunder.
“
GAAP ” shall mean generally accepted accounting
principles applied on a consistent basis as used in the United
States of America.
“
Governmental Body ” shall mean any government or
governmental or quasi-governmental authority including, without
limitation, any federal, state, territorial, county, municipal or
other governmental or quasi-governmental agency, board, branch,
bureau, commission, court, arbitral body (public or private),
department or other instrumentality or political unit or
subdivision, whether located in the United States or abroad, or the
Nasdaq Global Market.
“ Interim
Date ” shall have the meaning set forth in
Section 3.05.
“
Investor ” shall have the meaning set forth in the
preamble.
“ Law
” shall mean any treaty, statute, ordinance, code, rule,
regulation, Order or other legal requirement enacted, adopted,
promulgated, applied or followed by any Governmental
Body.
“
Legend ” shall have the meaning set forth in
Section 8.13(a).
“
Lien ” shall mean any mortgage, pledge, lien
(statutory or otherwise), security interest, hypothecation,
conditional sale agreement, encumbrance or similar restriction or
agreement.
“
Litigation ” shall have the meaning set forth in
Section 3.11.
2
“
Losses ” shall mean any and all damages, fines, fees,
taxes, penalties, deficiencies, losses and expenses, including
interest, reasonable expenses of investigation, court costs,
reasonable fees and expenses of attorneys, accountants and other
experts or other expenses of litigation or other proceedings or of
any claim, default or assessment (including without limitation fees
and expenses of attorneys incurred in connection with the
investigation or defense of any claim, default or assessment or
asserting or disputing any rights under this Agreement).
“
Material Adverse Effect ” shall mean any event,
condition or contingency that has had, or is reasonably likely to
have, a material adverse effect on the business, assets,
liabilities (including contingent liabilities), results of
operations or financial condition of the Company and its
subsidiaries, taken as a whole. For the purposes of this Agreement,
a Material Adverse Effect shall not be deemed to arise by reason of
(i) the transactions contemplated hereby, (ii) events of
war or terrorism impacting the economy in general, and
(iii) changes in general economic conditions or in the
exhibition industry, in general, except to the extent such changes
disproportionately and adversely affect the Company and its
subsidiaries, taken as a whole.
“
Notes ” shall have the meaning set forth in
Section 5.06.
“
Order ” shall mean any order, injunction, judgment,
decree, ruling, writ, assessment or arbitration award.
“ Other
Investors ” shall have the meaning set forth in
Section 5.06.
“ Other
Notes ” shall have the meaning set forth in
Section 5.06.
“
Permit ” shall mean any approval, authorization,
license, permit or certificate by or of any Governmental
Body.
“
Person ” shall mean any individual, corporation,
partnership, firm, limited liability company, joint venture, trust,
association, unincorporated organization, group, joint-stock
company or other entity.
“
Proposals ” shall have the meaning set forth in
Section 5.01.
“
Purchase Price ” shall have the meaning set forth in
Section 2.01.
“
Registration Rights Agreement ” shall have the meaning
set forth in Section 6.01(f).
“
Regulation D ” shall have the meaning set forth
in Section 3.09.
“ SEC
” shall mean the U.S. Securities and Exchange
Commission.
“
Securities Act ” shall mean the Securities Act of
1933, as amended, and the rules and regulations of the SEC
promulgated thereunder.
“
Subsequent Financing ” shall have the meaning set
forth in the Convertible Note.
3
“
Transaction Documents ” shall mean this Agreement, the
schedules and exhibits hereto, the Convertible Note, the Warrant,
the Registration Rights Agreement and any certificate or other
document delivered by or on behalf of the Company or the Investor
in connection with the Closing, and, commencing at the
effectiveness of any agreement or other document that is executed
by the parties hereto in accordance with Section 7 of the
Convertible Note (excluding agreements or documents executed in
connection with a Subsequent Financing), shall, for the limited
purposes of Sections 7.01, 7.02, 8.06, 8.07, 8.08 and 8.14,
include any such agreement or other document.
“
Warrant ” shall have the meaning set forth in the
Convertible Note.
Section 1.02.
Rules of Construction . Unless the context otherwise
requires:
(a) an
accounting term defined by GAAP that is not otherwise defined
herein has the meaning assigned to it in accordance with
GAAP;
(b) words in
the singular include the plural, and words in the plural include
the singular;
(c) the words
“include” and “including” shall be deemed
to mean “include, without limitation,” and
“including, without limitation”;
(d) “herein,”
“hereof,” “hereto,” “hereunder”
and other words of similar import refer to this Agreement as a
whole and not to any particular article, section, paragraph or
clause where such terms may appear; and
(e) references
to articles and sections mean references to such section in this
Agreement, unless stated otherwise.
ISSUANCE, SALE AND PURCHASE OF
THE CONVERTIBLE NOTE
Section 2.01.
Sale and Purchase of the Convertible Note . Upon the terms
and subject to the conditions of this Agreement, on the Closing
Date, the Company will sell to the Investor, and the Investor will
purchase from the Company, the Convertible Note in the principal
amount set forth on Schedule A , for an aggregate
purchase price equal to the principal amount of the Convertible
Note (the “ Purchase Price ”).
(a) Subject
to the satisfaction or waiver of the conditions set forth in this
Agreement, the closing of the transactions contemplated by
Section 2.01 (the “ Closing ”) shall,
subject to the parties’ respective rights to terminate this
Agreement in accordance with Section 8.12, take
place
4
on the date
hereof or as promptly thereafter as practicable as mutually agreed
to by the Company and the Investor, but in no event later than
Monday, May 11, 2009 (the date on which the Closing occurs
being the “ Closing Date ”). The Closing shall
occur at such place as is mutually agreeable by the parties
hereto.
(b) At the
Closing: (i) the Company will deliver to the Investor the
Convertible Note to be sold in accordance with the provisions of
Section 2.01 payable to the Investor; (ii) the Investor
shall pay to the Company the Purchase Price, by wire transfer of
immediately available funds; and (iii) each party shall take
or cause to happen such other actions, and shall execute and
deliver such other instruments or documents, as shall be required
under Article VI.
REPRESENTATIONS AND WARRANTIES OF
THE COMPANY
The Company
represents and warrants to the Investor as follows:
Section 3.01.
Organization and Good Standing . The Company is a
corporation duly incorporated, validly existing and in good
standing under the Laws of the State of Florida, has full corporate
power and authority to own, lease and operate its properties, and
carry on its business as presently conducted. The Company is duly
qualified, registered or licensed as a foreign corporation to do
business and is in good standing in each jurisdiction in which the
ownership or leasing of its properties or the character of its
present operations makes such qualification, registration or
licensing necessary, except where the failure to so qualify or be
in good standing would not reasonably be expected to have a
Material Adverse Effect.
Section 3.02.
Authority; Binding Effect . The Company has full corporate
power and authority to execute and deliver this Agreement and the
other Transaction Documents, and to perform its obligations
hereunder and thereunder. Subject to approval of the Proposals by
the Company’s shareholders, the execution and delivery of
this Agreement and the other Transaction Documents and the
consummation by the Company of the transactions contemplated hereby
and thereby have been duly and validly approved by all necessary
corporate action on the part of the Company. This Agreement has
been duly executed and delivered by the Company and constitutes the
legal, valid and binding obligation of the Company, enforceable in
accordance with its terms. The other Transaction Documents, when
executed and delivered by the Company, will be duly executed and
delivered by the Company and constitute legal, valid and binding
obligations of the Company, enforceable in accordance with their
respective terms, except (i) as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, or other laws of general application relating to or
affecting the enforcement of creditors’ rights generally,
(ii) as limited by laws relating to the availability of
specific performance, injunctive relief, or other equitable
remedies, or (iii) to the extent the indemnification provisions
contained in the Transaction Documents may be limited by applicable
federal or state securities laws.
Section 3.03.
Capitalization; Subsidiaries . As of the date hereof, the
authorized capital stock of the Company consists of 40,000,000
shares of Common Stock. As of the date hereof,
5
there are
30,548,581 shares of Common Stock issued and outstanding,
(ii) 1,066,449 shares of Common Stock held in treasury, and
(iii) 2,775,602 shares of Common Stock reserved for issuance
upon the exercise or conversion, as applicable, of outstanding
options or restricted stock units issued by the Company to its
employees and directors. Except as set forth in clauses (i),
(ii) and (iii) above, there are no shares of Common Stock
reserved for the issuance upon the exercise, conversion or exchange
of any securities of the Company. All of the issued and outstanding
shares of Common Stock have been duly and validly authorized and
issued and are fully paid and non-assessable and are not subject to
any preemptive rights. The Company is not subject to any obligation
(contingent or otherwise) to repurchase or otherwise acquire any
shares of its Common Stock. The Conversion Shares and the Warrant,
when issued in accordance with the terms hereof and the Convertible
Note or the Warrant, as applicable, will be duly authorized,
validly issued, fully paid and non-assessable and free and clear of
any Liens, and not subject to any preemptive rights, rights of
first refusal and restrictions on transfer, other than restrictions
on transfer contained in the Convertible Note or Warrant, as
applicable, or under applicable federal or state securities laws.
The Company has no subsidiaries other than the subsidiaries listed
on Exhibit 21.1 of the Company’s Annual Report on Form
10-K for the fiscal year ended February 29, 2008.
Section 3.04.
No Violations; Consents . Except as set forth on
Schedule 3.04 , neither the execution, delivery or
performance by the Company of this Agreement or the other
Transaction Documents, nor the consummation of the transactions
contemplated hereby or thereby, will (a) conflict with, or
result in the breach of, any provision of the articles of
incorporation or by-laws of the Company, as the same have been
amended from time to time, (b) conflict with, violate, result
in the breach or termination of, or constitute a default or give
rise to any right of termination or acceleration or right to
increase the obligations or otherwise modify the terms thereof
under any Contract, Permit or Order to which the Company is a party
or by which the Company or any of the properties or assets of the
Company is bound, (c) constitute a violation of any Law
applicable to the Company or (d) result in the creation of any
Lien upon the properties or assets of the Company (other than the
Liens pursuant to the transactions contemplated by the Transaction
Documents and pursuant to any Subsequent Financing), other than,
with respect to the foregoing clauses (b), (c) and (d), such
requirements, conflicts, violations, breaches or rights that would
not reasonably be expected to result in costs and/or liabilities in
excess of $250,000. Except as set forth on
Schedule 3.04 , no material Consent is required on the
part of the Company in connection with the execution and delivery
of this Agreement or the Transaction Documents, or the compliance
by the Company with any of the provisions hereof or
thereof.
Section 3.05.
Financial Statements . The consolidated balance sheet of the
Company as of February 29, 2008 and the related consolidated
income statements, changes in stockholders’ equity and cash
flows for the fiscal year ended February 29, 2008, as reported
in the Company’s Annual Report on Form 10-K for the fiscal
year ended February 29, 2008, filed by the Company with the
SEC under the Exchange Act, and accompanied by the audit report of
Kempisty & Company Certified Public Accountants, P.C.,
independent public accountants, present fairly, in all material
respects, the consolidated financial position of the Company and
the consolidated results of its operations and its cash flows for
the periods and dates covered thereby, in conformity with GAAP. The
unaudited consolidated balance sheet of the Company as
of
6
November 30, 2008 and the related unaudited
consolidated income statements and cash flows for the nine months
ended November 30, 2008, as reported in the Company’s
Quarterly Report on Form 10-Q for the quarterly period ended
November 30, 2008 (the “ Interim Date ”),
filed with the SEC under the Exchange Act, present fairly, in all
material respects, the consolidated financial position of the
Company and the consolidated results of its operations and its cash
flows for the periods and dates covered thereby, in conformity with
GAAP, except for changes resulting from year-end adjustments and
the absence of footnote disclosures thereto.
Section 3.06.
Commission Filings . The Company has filed all reports,
proxy statements and other materials, together with any amendments
required to be made with respect thereto, that were required to be
filed with the SEC under the Exchange Act from and after
January 1, 2008 (all such reports and statements are
collectively referred to herein as the “ Commission
Filings ”).
Section 3.07.
Private Placement . Assuming the representations and
warranties of the Investor contained in Article IV are true,
the offer and sale of the Convertible Note (and the issuance of the
Conversion Shares upon the conversion of such Convertible Note) are
exempt from the registration requirements of the Securities Act.
The Company has not taken and will not take any actions which would
cause the offers and sales contemplated hereunder to become
ineligible for exemption under the Securities Act. Neither the
Company nor any Person acting on its behalf has offered the
Convertible Note or any similar notes to any Person by means of
general or public solicitation or general or public advertising,
such as by newspaper or magazine advertisements, by broadcast
media, or at any seminar or meeting whose attendees were solicited
by such means.
Section 3.08.
Financial Advisors . Except as set forth on
Schedule 3.08 , no agent, broker, investment banker,
finder, financial advisor or other Person is or will be entitled to
any broker’s or finder’s fee or any other commission or
similar fee from the Company, directly or indirectly, in connection
with the transactions contemplated hereby.
Section 3.09.
No General Solicitation . None of the Company or any of its
“affiliates” (as defined in Rule 501(b) of
Regulation D under the Securities Act (“
Regulation D ”)), has, directly or through an
agent, engaged in any form of general solicitation or general
advertising in connection with the offering of the Notes (as those
terms are used in Regulation D) under the Securities Act or in
any manner involving a public offering within the meaning of
Section 4(2) of the Securities Act; and the Company has not
entered into any contractual arrangement with respect to the
distribution of the Convertible Note or any similar notes except
for this Agreement and the Transaction Documents, and the Company
will not enter into any such arrangement.
Section 3.10.
Debt Instruments; Liens and Encumbrances . After giving
effect to the transactions contemplated hereby, and except as set
forth on Schedule 3.10 or for the Transaction
Documents, there are no loan agreements, promissory notes, letters
of credit, security agreements, or other financing documents or
similar agreements (other than trade accounts payable and in
connection with the finance of insurance premiums and the lease of
office equipment in the ordinary course of business), to which the
Company or any of its subsidiaries is a party, whether as the
debtor, account party, guarantor or co-obligor, as the case may be,
or by which the Company or any of its subsidiaries or any of their
respective assets or property is
7
bound. Except
as set forth on Schedule 3.10 or pursuant to the
Transaction Documents, there are no Liens on any of the
Company’s or any of its subsidiaries’ assets or
properties. Except as set forth on Schedule 3.10 or
pursuant to the Convertible Note, as of the date hereof, neither
the Company nor any of its subsidiaries has any indebtedness for
borrowed money. Except as set forth on Schedule 3.10 ,
neither the Company nor any of its subsidiaries has filed, nor is
there is on record, a financing statement under the Uniform
Commercial Code (or similar statement or instrument of registration
under the law of any jurisdiction) naming the Company or any of its
subsidiaries as debtor.
Section 3.11.
Litigation . No claim, action, suit, investigation or other
proceeding is pending against the Company or any of its
subsidiaries or, to the Company’s actual knowledge, is
currently threatened in writing that questions the validity of this
Agreement or the other Transaction Documents or the right of the
Company to enter into this Agreement or the other Transaction
Documents or to consummate the transactions contemplated hereby or
thereby (“ Litigation ”). Except as set forth in
Schedule 3.11 , none of such Litigation would, if
determined adversely, reasonably be expected to have a Material
Adverse Effect. Neither the Company nor any of its subsidiaries is
a party or subject to any writ, order, decree, injunction or
judgment of any court, governmental agency or instrumentality (and
to the Company’s actual knowledge, there is no reasonable
basis, as of the date hereof, therefor or threat thereof) that
questions the validity of this Agreement or the Transaction
Documents or the right of the Company to enter into this Agreement
or the Transaction Documents or to consummate the transactions
contemplated hereby or thereby.
Section 3.12.
Insurance . All insurance policies maintained by the Company
and its subsidiaries are with reputable insurance carriers, are in
such amounts and provide coverage against such customary risks
incident to the business of the Company and its subsidiaries and
their properties and assets, are in character and amount and have
deductibles consistent with coverage carried by reasonab
|